Treatment of the acute disease is aimed at preventing further inflammatory reactions and spreading of PLE lesions over greater areas, alleviating clinical symptoms of itch, and hastening the resolution of skin changes.[1]Holzle E, Plewig G, von Kries R, et al. Polymorphous light eruption. J Invest Dermatol. 1987;88(3 Suppl):32s-8.
http://www.ncbi.nlm.nih.gov/pubmed/3819473?tool=bestpractice.com
[10]Dummer R, Ivanova K, Scheidegger EP, et al. Clinical and therapeutic aspects of polymorphous light eruption. Dermatology. 2003;207(1):93-5.
http://www.ncbi.nlm.nih.gov/pubmed/12835565?tool=bestpractice.com
Strict avoidance of sustained ultraviolet radiation exposure (even under shady umbrellas as UV-A can penetrate this material) is advised.[1]Holzle E, Plewig G, von Kries R, et al. Polymorphous light eruption. J Invest Dermatol. 1987;88(3 Suppl):32s-8.
http://www.ncbi.nlm.nih.gov/pubmed/3819473?tool=bestpractice.com
[10]Dummer R, Ivanova K, Scheidegger EP, et al. Clinical and therapeutic aspects of polymorphous light eruption. Dermatology. 2003;207(1):93-5.
http://www.ncbi.nlm.nih.gov/pubmed/12835565?tool=bestpractice.com
[60]Ling TC, Dawe RS, Gardener E, et al. Interventions for polymorphic light eruption. Cochrane Database Syst Rev. 2017 Oct 9;2017(10):CD005069.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005069.pub3/full
Acute therapy for PLE is easy and efficient, although often not necessary. The key to effective management involves prophylaxis, which is often much more difficult to achieve.
Papular type
Topical corticosteroids (of low potency) in a water-based formulation (spray, gel, lotion, or cream) are given as initial acute therapy together with emollients.[60]Ling TC, Dawe RS, Gardener E, et al. Interventions for polymorphic light eruption. Cochrane Database Syst Rev. 2017 Oct 9;2017(10):CD005069.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005069.pub3/full
For most people with PLE these measures will be sufficient to lead to a timely resolution of all symptoms and skin changes, without permanent damage.[1]Holzle E, Plewig G, von Kries R, et al. Polymorphous light eruption. J Invest Dermatol. 1987;88(3 Suppl):32s-8.
http://www.ncbi.nlm.nih.gov/pubmed/3819473?tool=bestpractice.com
[10]Dummer R, Ivanova K, Scheidegger EP, et al. Clinical and therapeutic aspects of polymorphous light eruption. Dermatology. 2003;207(1):93-5.
http://www.ncbi.nlm.nih.gov/pubmed/12835565?tool=bestpractice.com
Plaque and papular-vesicular types
For mild plaque-type PLE (few small plaques), topical corticosteroids (of low potency) and emollients are sufficient for resolution of symptoms.[1]Holzle E, Plewig G, von Kries R, et al. Polymorphous light eruption. J Invest Dermatol. 1987;88(3 Suppl):32s-8.
http://www.ncbi.nlm.nih.gov/pubmed/3819473?tool=bestpractice.com
[10]Dummer R, Ivanova K, Scheidegger EP, et al. Clinical and therapeutic aspects of polymorphous light eruption. Dermatology. 2003;207(1):93-5.
http://www.ncbi.nlm.nih.gov/pubmed/12835565?tool=bestpractice.com
For patients with a more inflammatory response, such as thick plaques in plaque-type PLE or blister formation in the vesiculobullous variant of PLE, more potent corticosteroid formulations may be effective. This may be combined with nonsteroidal anti-inflammatory drugs.
In very rare cases, such as pronounced erythema exudativum multiforme type or widespread bullae, a short course of systemic corticosteroids might be considered in addition to the above treatments.